Concerns about the use of Risperdal in children have continued to grow recently, with a settlement from Johnson & Johnson over the off-label treatment of the medication, as well as its association with gynecomastia, a condition categorized by male breast growth, in young boys.
In addition to the rising number of Risperdal lawsuits filed over the use of Risperidone in children, Johnson & Johnson paid $2.2 billion to resolve criminal and civil charges involving the company’s off-label promotion of the drug. This settlement was filed with the U.S. Department of Justice and reached in November 2013.
For more information about Risperdal and its alleged complications in children, call the lawyers at Bernstein Liebhard LLP to start the process of filing a claim against Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, Inc. The Firm can be reached at .
In November 2013, Johnson & Johnson agreed to pay $2.2 billion in civil and criminal charges to the U.S. Department of Justice after a government investigation found that the company prescribed Risperdal, as well as certain other drugs, off-label to children, elderly patients with dementia, and individuals suffering from mental disabilities. The company also reportedly paid Omnicare Inc., the largest drug supplier for nursing homes, to promote Risperdal.
This news comes as the association between Risperdal and male gynecomastia in men and young boys continues to make headlines. Approved to treat schizophrenia in adults and adolescents, as well as bipolar disorder in adults and children between the ages of 10 and 17, the anti-psychotic medication was reportedly involved in Johnson & Johnson’s settlement of five lawsuits in October 2012. According to a report from Bloomberg.com, the cases had been filed in the Philadelphia Court of Common Pleas.
Court records indicate that several more have been filed at this location, many of which alleging complications stemming from the use of Risperidone in children.
Risperdal gynecomastia is the development of breast tissue development in men and boys treated with the medication. According to a wave of studies, this may be caused by Risperdal’s potential to overproduce prolactin, a hormone associated with breast growth and milk production in women. A growing number of lawsuits filed over the medication allege that gynecomastia complications may only be reversed through liposuction and mastectomy procedures to remove the excess breast tissue.
Symptoms associated with Risperdal gynecomastia in children may include:
In addition to reports of men and young boys developing breasts as large as D cups, many Risperdal patients have also allegedly experienced unexpected milk production.
If you or a man you love experienced gynecomastia or another complication stemming from the use of Risperdal (Risperidone) in children, contact our Firm today to learn if you are eligible to file a claim. Call one of our lawyers today at .